HUS1 and urinary bladder carcinoma: When analyzing the sequence of interest in detail, 7p12.2–p11.2 prioritized genes that had not previously been reported as regulators of platinum-based chemotherapy responses in bladder cancer including HUS1, ABCA13, IKZF1, EGFR, and FIGNL1 [12].